Dr. Reddy's Laboratories Limited - 存託憑證(普通股)
US ˙ NYSE ˙ US2561352038

SecurityRDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
InstitutionBlackRock, Inc.
Latest Disclosed Ownership7,216,922 shares
Ownership 4.30%
BlackRock, Inc. ownership in RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)

2020-04-09 - BlackRock, Inc. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,216,922 shares of Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock) (US:RDY). This represents 4.3 percent ownership of the company. In their previous filing dated 2020-02-07 , BlackRock, Inc. had reported owning 8,409,714 shares, indicating a decrease of -14.18 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2020-04-09 2020-04-09 13G/A 8,409,714 7,216,922 -14.18 4.30 -15.69
2020-02-07 2020-02-07 13G 8,042,301 8,409,714 4.57 5.10 4.08
2019-12-10 2019-12-10 13G/A 11,183,123 8,042,301 -28.09 4.90 -26.87
2019-02-08 2019-02-08 13G 11,183,123 11,183,123 0.00 6.70 0.00
2019-02-07 2019-02-07 13G 11,183,123 6.70

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F DR REDDYS LABS ADR 256135203 11,587,127 1,289,122 12.52 160,482 11.00 0.0002
2026-02-12 2025-12-31 13F DR REDDYS LABS ADR 256135203 10,298,005 -862,393 -7.73 144,584 -7.33 0.0024
2025-11-12 2025-09-30 13F DR REDDYS LABS ADR 256135203 11,160,398 724,151 6.94 156,022 -0.53 0.0027
2025-08-12 2025-06-30 13F DR REDDYS LABS ADR 256135203 10,436,247 1,965,255 23.20 156,857 40.39 0.0030
2025-05-02 2025-03-31 13F DR REDDYS LABS ADR 256135203 8,470,992 -1,551,730 -15.48 111,732 -29.40 0.0023
2025-02-07 2024-12-31 13F DR REDDYS LABS ADR 256135203 10,022,722 8,106,767 423.12 158,259 3.97 0.0032
2024-11-13 2024-09-30 13F DR REDDYS LABS ADR 256135203 1,915,955 113,920 6.32 152,223 10.87 0.0032
2024-08-13 2024-06-30 13F DR REDDYS LABS ADR 256135203 1,802,035 -376,423 -17.28 137,297 -14.08 0.0031
2024-05-10 2024-03-31 13F DR REDDYS LABS ADR 256135203 2,178,458 -822,962 -27.42 159,790 -23.49 0.0037
2024-02-13 2023-12-31 13F DR REDDYS LABS ADR 256135203 3,001,420 517,270 20.82 208,839 25.72 0.0053
2023-11-13 2023-09-30 13F DR REDDYS LABS ADR 256135203 2,484,150 524,524 26.77 166,115 34.32 0.0048
2023-08-11 2023-06-30 13F DR REDDYS LABS ADR 256135203 1,959,626 -343,437 -14.91 123,672 -5.68 0.0034
2023-05-12 2023-03-31 13F DR REDDYS LABS ADR 256135203 2,303,063 462,799 25.15 131,113 37.68 0.0039
2023-02-13 2022-12-31 13F DR REDDYS LABS ADR 256135203 1,840,264 145,387 8.58 95,234 7.35 0.0030
2022-11-14 2022-09-30 13F DR REDDYS LABS ADR 256135203 1,694,877 83,146 5.16 88,710 -0.63 0.0030
2022-08-12 2022-06-30 13F DR REDDYS LABS ADR 256135203 1,611,731 27,840 1.76 89,273 1.14 0.0029
2022-05-12 2022-03-31 13F DR REDDYS LABS ADR 256135203 1,583,891 30,341 1.95 88,271 -13.13 0.0024
2022-02-10 2021-12-31 13F DR REDDYS LABS ADR 256135203 1,553,550 189,155 13.86 101,617 14.33 0.0026
2021-11-09 2021-09-30 13F DR REDDYS LABS ADR 256135203 1,364,395 24,935 1.86 88,877 -9.74 0.0025
2021-08-11 2021-06-30 13F DR REDDYS LABS ADR 256135203 1,339,460 31,844 2.44 98,463 22.66 0.0027
2021-05-07 2021-03-31 13F DR REDDYS LABS ADR 256135203 1,307,616 515,184 65.01 80,274 42.10 0.0024
2021-02-05 2020-12-31 13F DR REDDYS LABS ADR 256135203 792,432 -76,908 -8.85 56,493 -6.58 0.0018
2020-11-06 2020-09-30 13F DR REDDYS LABS ADR 256135203 869,340 -161,382 -15.66 60,472 10.67 0.0022
2020-08-14 2020-06-30 13F DR REDDYS LABS ADR 256135203 1,030,722 -182,707 -15.06 54,640 11.66 0.0022
2020-05-01 2020-03-31 13F DR REDDYS LABS ADR 256135203 1,213,429 -563,287 -31.70 48,936 -32.13 0.0024
2020-02-13 2019-12-31 13F DR REDDYS LABS ADR 256135203 1,776,716 57,516 3.35 72,098 10.68 0.0028
2019-11-08 2019-09-30 13F DR REDDYS LABS ADR 256135203 1,719,200 -247,345 -12.58 65,141 -11.60 0.0027
2019-08-22 2019-06-30 13F/A-1 DR REDDYS LABS ADR 256135203 1,966,545 179,778 10.06 73,688 1.83 0.0032
2019-08-13 2019-06-30 13F DR REDDYS LABS ADR 256135203 1,966,545 179,778 73,688
2019-05-09 2019-03-31 13F DR REDDYS LABS ADR 256135203 1,786,767 -191,648 -9.69 72,364 -2.98 0.0032
2019-02-08 2018-12-31 13F DR REDDYS LABS ADR 256135203 1,978,415 242,856 13.99 74,588 24.21 0.0038
2018-11-09 2018-09-30 13F DR REDDYS LABS ADR 256135203 1,735,559 175,791 11.27 60,049 19.56 0.0026
2018-08-09 2018-06-30 13F DR REDDYS LABS ADR 256135203 1,559,768 153,920 10.95 50,225 9.29 0.0023
2018-05-09 2018-03-31 13F DR REDDYS LABS ADR 256135203 1,405,848 199 0.01 45,956 -12.96 0.0022
2018-02-09 2017-12-31 13F DR REDDYS LABS ADR 256135203 1,405,649 -71,209 -4.82 52,796 0.19 0.0025
2017-11-14 2017-09-30 13F DR REDDYS LABS ADR 256135203 1,476,858 188,302 14.61 52,694 -2.96 0.0027
2017-08-10 2017-06-30 13F DR REDDYS LABS ADR 256135203 1,288,556 -69,496 -5.12 54,299 -0.42 0.0029
2017-05-12 2017-03-31 13F DR REDDYS LABS ADR 256135203 1,358,052 1,331,604 5,034.80 54,527 4,451.50 0.0030
2017-02-10 2016-12-31 13F DR REDDYS LABS ADR 256135203 26,448 -401 -1.49 1,198 -3.85 0.0017
2016-11-08 2016-09-30 13F DR REDDYS LABS ADR 256135203 26,849 -17 -0.06 1,246 -9.45 0.0018
2016-08-10 2016-06-30 13F DR REDDYS LABS ADR 256135203 26,866 -19,559 -42.13 1,376 -34.41 0.0021
2016-05-10 2016-03-31 13F DR REDDYS LABS ADR 256135203 46,425 10,807 30.34 2,098 27.23 0.0034
2016-02-11 2015-12-31 13F DR REDDYS LABS ADR 256135203 35,618 -48,815 -57.82 1,649 -69.44 0.0024
2015-11-13 2015-09-30 13F DR REDDYS LABS ADR 256135203 84,433 48,039 132.00 5,396 168.06 0.0085
2015-08-07 2015-06-30 13F DR REDDYS LABS ADR 256135203 36,394 -20,219 -35.71 2,013 -37.74 0.0030
2015-05-13 2015-03-31 13F DR REDDYS LABS ADR 256135203 56,613 -17,817 -23.94 3,233 -13.90 0.0045
2015-02-09 2014-12-31 13F DR REDDYS LABS ADR 256135203 74,430 -4,861 -6.13 3,755 -9.89 0.0054
2014-10-29 2014-09-30 13F DR REDDYS LABS ADR 256135203 79,291 -1,613 -1.99 4,167 19.36 0.0061
2014-08-06 2014-06-30 13F DR REDDYS LABS ADR 256135203 80,904 -3,214 -3.82 3,491 -5.44 0.0052
2014-05-02 2014-03-31 13F DR REDDYS LABS ADR 256135203 84,118 12,232 17.02 3,692 25.19 0.0060
2014-02-12 2013-12-31 13F DR REDDYS LABS ADR 256135203 71,886 2,620 3.78 2,949 12.64 0.0048
2013-11-12 2013-09-30 13F DR REDDYS LABS ADR 256135203 69,266 5,894 9.30 2,618 9.22 0.0049
2013-08-13 2013-06-30 13F DR REDDYS LABS ADR 256135203 63,372 63,372 2,397 0.0048
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.